Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Central Nervous System Neoplasms × ribociclib × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Glioma 3 Ovarian Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Endocrine Neoplasia Type 1 2 Melanoma 2 Diffuse Intrinsic Pontine Glioma 2 Thymus Neoplasms 1 Teratoma 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Osteitis Deformans 1 Non functioning pancreatic endocrine tumor 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Mesothelioma 1 Medulloblastoma 1 Lymphoma 1 Leukemia 1 Hematologic Neoplasms 1 Glioblastoma 1 Familial ependymoma 1 Fallopian Tube Neoplasms 1 Estrogen Receptor and/or Progesterone Receptor Positive 1 Cystadenocarcinoma, Serous 1 Breast Neoplasms, Male 1

Interventions

Temozolomide 28 Radiotherapy 20 Bevacizumab 9 Carboplatin 8 Radiation 6 Filgrastim 6 Etoposide 6 Magnetic Resonance Spectroscopy 5 Irinotecan 5 Cyclophosphamide 5 etoposide phosphate 4 Vincristine 4 Ifosfamide 4 Granulocyte Colony-Stimulating Factor 4 Everolimus 4 X-Rays 3 Thalidomide 3 Specimen Handling 3 Phantoms, Imaging 3 Lomustine 3 Cisplatin 3 Chemotherapy, Adjuvant 3 Celecoxib 3 vitespin 2 poly ICLC 2 larotrectinib 2 Thiotepa 2 Rituximab 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Conformal 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡